Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Ocata Therapeutics
ClinicalTrials.gov Identifier:
NCT01345006
First received: April 28, 2011
Last updated: April 27, 2015
Last verified: April 2015